Riskpilot← Back to searchSign inGet full accessSelskabet af 1999 ApS
APSDissolvedCVR 29317453Danstrupvej 27GWholesale of pharmaceutical and medical goods · NACE 4646Est. 20051 employees
Revenue 2024
DKK 269K
+541% vs 2023
EBITDA margin
43.5%
+130% vs 2023
Equity ratio
-20.6%
Financial strength
Net profit 2024
DKK 19K
+108% vs 2023
| Revenue | DKK 269K | +541% |
| EBITDA | DKK 117K | +130% |
| Net profit | DKK 19K | +108% |
| Total assets | DKK 978K | -26% |
| Equity | DKK -202K | +9% |
| Employees | 1 | — |
Legal name
Selskabet af 1999 ApS
CVR number
29317453
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
5. december 2005
Share capital
DKK 416.667
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen og bestyrelsesformanden i forening eller den samlede bestyrelse.
Address
Danstrupvej 27G
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 762 | 873 | 406 | 42 | 269 |
| Staff expenses | -586 | -772 | -471 | -433 | -152 |
| EBITDA | 176 | 101 | -65 | -391 | 117 |
| Depreciation & amort. | -0 | -6 | -6 | -6 | -6 |
| EBIT | 176 | 95 | -71 | -397 | 111 |
| Net financials | -156 | -72 | -65 | 156 | -92 |
| Profit before tax | 21 | 23 | -137 | -241 | 19 |
| Tax | -0 | -0 | -0 | -11 | -0 |
| Net profit | 21 | 23 | -137 | -230 | 19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.800 | 1.530 | 1.680 | 1.325 | 978 |
| Equity | 123 | 146 | 9 | -221 | -202 |
| Long-term debt | 200 | 87 | 0 | 0 | 0 |
| Short-term debt | 1.477 | 1.296 | 1.671 | 1.546 | 1.180 |
| Total debt | 1.677 | 1.384 | 1.671 | 1.546 | 1.180 |
EBITDA margin
43.5%
This company
15.8%
Market median
+175% vs market
20202024
Equity ratio
-20.6%
This company
38.2%
Market median
-154% vs market
20202024
Return on equity
1896800.0%
This company
18.4%
Market median
+10308596% vs market
20202024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20202024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20202024
Debt / equity
5.85×
This company
0.62×
Market median
-844% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
HJ Management | Management | 2005 – 2008 |
CJ Management | Management | 2005 – 2011 |
CJ Management | Management | 2011 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2008 – 2013 | |
| Board of Directors | 2008 – 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10–14.99% | 10–14.99% | 2009 | |
| Company | 90–99.99% | 90–99.99% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Selskabet af 1999 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Juel Olsson | Management | 0 companies |
| Claus Juel Madsen | Management | 0 companies |
| Camilla Juel Madsen | Management | 0 companies |
| Tue Schøth Skovgaard | Board of Directors | 0 companies |
| Bent Ulrik Sort | Board of Directors | 0 companies |